查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1995440

肺計量計市場：全球市場按產品類型、測量方法、最終用戶、應用和銷售管道分類的預測 - 2026-2032 年

Spirometer Market by Product Type, Technique, End User, Application, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，肺計量計市場價值將達到 14.1 億美元，到 2026 年將成長到 15.1 億美元，到 2032 年將達到 25.4 億美元，複合年成長率為 8.75%。

主要市場統計數據
基準年 2025 14.1億美元
預計年份：2026年 15.1億美元
預測年份 2032 25.4億美元
複合年成長率 (%) 8.75%

本報告概述了肺活量測定的臨床意義、技術進步、監管趨勢、報銷考慮因素和相關人員的期望，並全面描述了這些因素如何影響設備的採用、臨床工作流程和採購重點。

肺功能測定仍然是呼吸整體中一項基礎性的診斷和監測工具，在阻塞性和限制性肺部疾病的診斷、圍手術全期評估以及慢性疾病的指南中發揮著至關重要的作用。近年來，儀器外形、測量技術和軟體功能的顯著進步，使得流速-容量分析更加快速且準確，並與電子健康系統實現了更好的整合。這些進步正在重塑臨床醫生、呼吸治療師和護理管理人員將肺功能測定融入日常實踐的方式，其應用範圍涵蓋門診手術中心、醫院診所、居家照護機構和實驗室等。

臨床實踐和設備工程的變革性變化，包括數位化整合、遠端患者監護、基於機器學習的診斷以及所有醫療保健環境中的工作流程自動化，正在重塑肺計量計的開發和部署。

在數位醫療融合、臨床路徑演進和監管力度加大的推動下，肺計量計領域正經歷著一場變革。設備正從獨立儀器轉向整合平台，這些平台能夠收集長期呼吸指標，支援遠距遠端醫療監測，並將數據提供給分析引擎，從而輔助診斷決策。這一趨勢反映了更廣泛的醫療保健重點，包括改善患者就醫途徑、加強慢性病管理以及透過早期療育減少不必要的住院。

評估 2025 年美國關稅政策變化對肺計量計系統中的零件採購、製造經濟、分銷物流、籌資策略、供應商多元化和下游臨床准入的累積影響。

美國2025年關稅政策的調整對整個肺計量計價值鏈上的相關人員提出了重大考量，影響籌資策略、供應商關係和零件採購決策。對於依賴跨境供應鏈的製造商而言，關稅帶來的成本壓力正促使他們重新評估零件採購和生產地點。一些公司正在加速供應商多元化，並探索替代製造地，以維持獲利能力和按時交付的可靠性。這種重組將影響設備前置作業時間和售後支援合約的趨勢。

細分市場的洞察揭示了最終用戶環境、產品類型、測量技術、臨床應用和銷售管道如何相互作用並影響儀器設計、服務交付模式、臨床醫生採納和購買行為。

對於相關人員，精準理解細分市場動態至關重要。對門診手術中心、診所、居家照護中心、醫院和實驗室等終端用戶環境的評估表明，每種環境都對性能、耐用性和連接性有著獨特的要求。門診手術中心優先考慮快速處理能力和易於消毒；診所需要面積小且能與電子健康記錄互通性；居家照護中心重視便攜性和以患者為中心的界面；醫院需要強大的維護性和校準流程；而實驗室則需要高精度測量和可客製化的數據輸出。

區域展望，整合了美洲、歐洲、中東和非洲以及亞太地區的需求推動要素、供應趨勢、監管和償還環境、分銷基礎設施以及採用者行為模式。

區域特徵對設備部署、監管預期、報銷途徑和分銷模式有顯著影響，進而影響製造商和供應商的策略選擇。在美洲，需求通常與整合醫療計劃、醫院整合趨勢以及對慢性病管理項目的投資密切相關，這些項目優先考慮利用互通性和分析能力提供醫療服務。在臨床實務中，能夠與電子健康記錄和遠端醫療平台整合的設備備受青睞，採購團隊除了考慮資本支出預算和臨床結果指標外，還會考慮長期服務合約。

領先肺計量計公司和新興參與企業的競爭格局和策略見解，重點關注創新管線、監管核准、臨床夥伴關係、製造策略、智慧財產權定位和市場進入方法。

肺計量計市場的競爭格局呈現出兩極化的特點：既有成熟的醫療設備製造商，也有專注於軟體驅動服務和細分應用的小規模創新參與企業。主要企業強調硬體、軟體和服務一體化的產品組合，不僅在硬體規格上脫穎而出，更注重整體臨床價值。這一趨勢在企業對雲端連接、遠端醫療相容性和分析能力的投資中體現得尤為明顯，這些投資旨在支持長期患者管理和臨床決策。

為製造商、經銷商、臨床採購負責人、技術整合商和政策制定者提供具體的策略建議，以降低供應風險、提供臨床價值、簡化核准流程並加速採用先進的肺功能測定解決方案。

產業領導企業可以採取多項切實可行的措施來鞏固市場地位、確保供應連續性並加速肺功能儀解決方案的臨床應用。首先，根據醫療機構的具體需求客製化產品設計——即確保攜帶式設備滿足居家照護的便利性要求，桌面系統符合檢查室檢驗標準——可以提高臨床接受度並減少部署阻力。其次，投資於軟體互通性和安全資料交換能力將帶來顯著成效，促進與電子健康記錄和遠端醫療平台的整合，從而將肺功能儀融入臨床醫生的工作流程。

穩健的研究方法，說明了主要訪談通訊協定、臨床和商業相關人員的受訪者抽樣、二手文獻的整合、供應鏈映射、數據三角測量以及臨床和調查方法專家的檢驗。

支持這些發現的研究結合了與臨床和商業相關人員的結構化一手調查，以及對同行評審文獻、監管文件和公共聲明的嚴謹二次整合。一手研究包括對肺科醫生、臨床採購經理、設備工程師和分銷合作夥伴的訪談，以直接了解他們對設備易用性、服務期望和採購標準的看法。這些定性資訊輔以對監管指南、已發表的臨床性能研究和產品技術規範的審查，以確保相關人員的需求與設備功能相符。

本報告重點關注臨床表現、互通性、監管合規性、供應彈性和商業化優先事項，總結出簡潔的結論，為醫療保健提供者、製造商、監管機構和投資者提供戰略意義。

總而言之，肺計量計市場正處於一個轉折點，臨床需求、技術創新和商業性壓力在此交匯，重新定義了設備的效用和部署模式。臨床醫生期望設備不僅能提供準確的生理測量數據，還能無縫融入患者的診療流程，支援遠端監測，並提供可操作的見解以改善治療效果。測量技術和連接性的技術進步正在幫助實現這些期望，而監管和採購方面的考慮則影響解決方案從原型到臨床應用的轉換過程。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：肺計量計市場：依產品類型分類

  • 桌面型
  • 可攜式的
  • 固定式

第9章：肺計量計市場：依技術分類

  • 肉
  • 渦輪型
  • 超音波型

第10章：肺計量計市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 居家照護中心
  • 醫院
  • 研究所

第11章：肺計量計市場：依應用領域分類

  • 成人版
  • 兒童

第12章：肺計量計市場：依銷售管道分類

  • 線下銷售
  • 線上銷售

第13章：肺計量計市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：肺計量計市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：肺計量計市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國肺計量計市場

第17章：中國肺計量計市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Baxter International Inc.
  • COSMED Srl
  • Fukuda Sangyo Co., Ltd.
  • Geratherm Respiratory GmbH
  • ICU Medical, Inc.
  • Jones Medical Instrument Company
  • Koninklijke Philips NV
  • Medical International Research SpA
  • MGC Diagnostics Corporation
  • Midmark Corporation
  • NDD Medical Technologies AG
  • NuvoAir AB
  • Schiller AG
  • Vitalograph Ltd.
  • Vyaire Medical, Inc.
Product Code: MRR-4103B31E03EC

The Spirometer Market was valued at USD 1.41 billion in 2025 and is projected to grow to USD 1.51 billion in 2026, with a CAGR of 8.75%, reaching USD 2.54 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.41 billion
Estimated Year [2026] USD 1.51 billion
Forecast Year [2032] USD 2.54 billion
CAGR (%) 8.75%

Comprehensive introduction outlining the clinical significance of spirometry technological advancements regulatory dynamics reimbursement considerations and stakeholder expectations that collectively shape device adoption, clinical workflows, and procurement priorities

Spirometry remains a cornerstone diagnostic and monitoring tool across respiratory medicine, integral to diagnosing obstructive and restrictive lung diseases, supporting perioperative assessment, and guiding chronic disease management. Over recent years device form factors, measurement techniques, and software capabilities have evolved substantially, enabling faster, more accurate flow-volume analyses and greater integration with electronic health systems. These advancements are reshaping how clinicians, respiratory therapists, and care managers incorporate spirometry into routine workflows, from ambulatory surgical centers and hospital clinics to homecare environments and research laboratories.

Clinicians increasingly expect not only reliable physiological measurement but also seamless interoperability, secure data transfer, and user-friendly interfaces that shorten training time and reduce variability. As a result, device manufacturers have directed investment toward ergonomic design, robust sensor technologies, and clinical validation studies to meet rigorous regulatory requirements. At the same time, payers and procurement teams are scrutinizing total cost of ownership and serviceability, prompting providers to prefer solutions that offer streamlined maintenance and remote support. Taken together, these clinical, technical, and commercial dynamics are creating a complex landscape where product differentiation is determined as much by ecosystem compatibility and service models as by raw measurement performance.

Transformative shifts in clinical practice and device engineering that are reshaping spirometer development and deployment, including digital integration, remote patient monitoring, machine learning diagnostics, and workflow automation across care settings

The spirometer landscape is undergoing transformative shifts driven by digital health convergence, evolving clinical pathways, and heightened regulatory scrutiny. Devices are moving beyond standalone instruments toward integrated platforms that capture longitudinal respiratory metrics, enable telehealth-enabled remote monitoring, and feed analytics engines that support diagnostic decision-making. This trajectory reflects broader healthcare priorities: improving patient access, enhancing chronic disease management, and reducing avoidable hospital encounters through earlier intervention.

Concurrently, measurement techniques and sensor technologies are diversifying. Traditional Fleisch systems continue to be prized for laboratory-grade precision, while turbine and ultrasonic solutions have advanced to deliver portable and stationary devices with improved durability and reduced calibration needs. Software innovations are enabling automated quality checks and clinician prompts that elevate usability in busy care settings. As a result, clinical workflows are adapting: ambulatory surgical centers and clinics are embedding spirometry more routinely into preoperative and chronic care protocols, while homecare programs increasingly adopt portable devices to support remote monitoring of adult and pediatric patients. These shifts are converging toward a future where spirometry is not simply a point-in-time diagnostic tool but a component of continuous respiratory care pathways empowered by data and connectivity.

Cumulative impact assessment of United States tariff policy changes in 2025 on component sourcing, manufacturing economics, distribution logistics, procurement strategies, supplier diversification, and downstream clinical access within the spirometer ecosystem

United States tariff policy adjustments in 2025 have introduced pronounced considerations for stakeholders across the spirometer value chain, affecting procurement strategies, supplier relationships, and component sourcing decisions. For manufacturers dependent on cross-border supply chains, tariff-driven cost pressures have prompted re-evaluation of component sourcing and production footprints, with some firms accelerating diversification of suppliers and exploring alternative manufacturing locations to preserve margins and delivery reliability. This realignment has implications for device lead times and the dynamics of aftermarket support contracts.

Procurement teams within hospitals, ambulatory centers, and large distributor networks have responded by incorporating tariff risk assessments into vendor selection processes and negotiating longer-term service agreements to stabilize lifecycle costs. In parallel, device developers are intensifying efforts to localize critical components, redesign assemblies to use less tariff-exposed parts, and increase transparency around bill-of-materials sourcing to build trust with buyers. Importantly, these supply chain adaptations are also influencing product roadmaps, as manufacturers balance innovation priorities with pragmatic choices aimed at sustaining supply continuity and regulatory compliance. Consequently, stakeholders across clinical, commercial, and regulatory domains must maintain agile sourcing strategies and closer collaboration to mitigate tariff-induced disruptions while ensuring uninterrupted access to high-quality spirometry solutions.

Segment-driven insights that reveal how end user environments, product types, measurement techniques, clinical applications, and sales channels interact to influence device design, service delivery models, clinician adoption, and purchasing behavior

A nuanced understanding of segmentation dynamics is critical for stakeholders aiming to align product development and go-to-market strategies with clinical and commercial needs. When evaluating end user environments such as ambulatory surgical centers, clinics, homecare centers, hospitals, and research laboratories, it becomes clear that each setting imposes distinct performance, durability, and connectivity requirements. Ambulatory surgical centers prioritize rapid throughput and ease of sterilization, clinics demand compact footprint and interoperability with electronic records, homecare centers emphasize portability and patient-centered interfaces, hospitals seek robust serviceability and calibration workflows, while research laboratories require high-fidelity measurement and customizable data outputs.

Product types-desktop, portable, and stationary devices-map directly to these end user expectations, with desktop instruments remaining common where bench-top precision is valued, portable devices enabling remote monitoring and home use, and stationary systems addressing high-volume clinical contexts. Measurement techniques, including Fleisch, turbine, and ultrasonic modalities, each bring trade-offs in accuracy, maintenance frequency, and cost of ownership, influencing where devices are most effectively deployed. Clinical applications for adults versus pediatric populations shape sensor sizing, flow range, and software validation protocols to ensure accurate interpretation across age groups. Finally, sales channel dynamics involving offline sales and online sales determine purchasing cadences, service models, and the degree of pre-sale clinical evaluation. Understanding how these segmentation elements interact enables manufacturers and purchasers to prioritize design attributes, training resources, and commercial terms that best fit specific care pathways and operational constraints.

Regional outlook synthesizing demand drivers, supply dynamics, regulatory and reimbursement environments, distribution infrastructure, and adopter behavior patterns across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions

Regional nuances exert a significant influence on device adoption, regulatory expectations, reimbursement pathways, and distribution models, shaping strategic choices for manufacturers and suppliers. In the Americas, demand is frequently tied to integrated care initiatives, hospital consolidation trends, and investments in chronic disease management programs that prioritize interoperability and analytics-enabled care. The clinical community values devices that integrate with electronic records and telehealth platforms, and procurement teams weigh long-term service agreements alongside capital budgets and clinical outcomes metrics.

Across Europe, the Middle East & Africa, regulatory harmonization and varied reimbursement environments create a patchwork of adoption drivers. National-level regulatory agencies and payer systems influence device certification timelines and evidence requirements, prompting manufacturers to align clinical validation dossiers with region-specific standards. Distribution strategies must account for logistical complexity and varying levels of clinical infrastructure, while partnerships with regional distributors and clinical networks often accelerate market entry. In the Asia-Pacific region, rapid digital health adoption, growing investment in outpatient and homecare services, and competitive manufacturing ecosystems drive both demand for portable, cost-effective devices and opportunities for localized production. Across all regions, ensuring supply chain resilience, adhering to local regulatory expectations, and tailoring commercial models to reimbursement realities are essential for successful deployment.

Competitive landscape and corporate strategic insights highlighting innovation pipelines, regulatory approvals, clinical partnerships, manufacturing strategies, intellectual property positioning, and go-to-market approaches among leading spirometer companies and emerging entrants

Competitive dynamics within the spirometer landscape are characterized by a mix of established medical device manufacturers and smaller innovative entrants focused on software-enabled services and niche applications. Leading firms emphasize integrated portfolios that combine hardware, software, and services to differentiate on total clinical value rather than hardware specifications alone. This trend is evident in investments toward cloud connectivity, telehealth compatibility, and analytics that support longitudinal patient management and clinical decision support.

At the same time, emerging companies are carving out positions by addressing unmet needs such as pediatric-specific devices, ultra-portable consumer-friendly models for home monitoring, and measurement modalities that reduce calibration requirements. Strategic partnerships between device developers and electronic health record vendors or telehealth platforms are becoming more common, enabling smoother clinical workflows and broader use-case coverage. Additionally, some manufacturers are exploring modular service offerings and subscription-based models that align payment with usage and ongoing support, reflecting a shift toward outcome-oriented commercial approaches. Across the competitive landscape, intellectual property portfolios, clinical validation evidence, and the ability to demonstrate interoperability and service reliability are decisive factors that influence adoption by health systems and clinician groups.

Actionable strategic recommendations for manufacturers, distributors, clinical purchasers, technology integrators, and policymakers to mitigate supply risks, capture clinical value, streamline approvals, and accelerate adoption of advanced spirometry solutions

Industry leaders can take several practical steps to strengthen market position, protect supply continuity, and accelerate clinical adoption of spirometry solutions. First, aligning product design with the specific needs of care settings-ensuring that portable devices meet homecare usability requirements while desktop systems satisfy laboratory validation standards-will enhance clinical acceptance and reduce implementation friction. Second, investing in software interoperability and secure data exchange capabilities pays dividends by facilitating integration into electronic records and telehealth platforms, thereby embedding spirometry into clinician workflows.

Third, strengthening supply chain resilience through supplier diversification, strategic onshoring of critical components, and flexible manufacturing agreements will mitigate exposure to trade policy fluctuations and logistics disruptions. Fourth, pursuing partnerships with clinical networks, payers, and distribution partners can accelerate adoption by demonstrating real-world value and simplifying procurement pathways. Fifth, offering comprehensive service agreements and digital training resources reduces total cost of ownership concerns for providers and supports higher-quality data capture. Finally, industry leaders should proactively engage with regulatory authorities and standards bodies to anticipate evidentiary requirements, ensuring that clinical validation and usability studies address regional expectations and expedite market access.

Robust research methodology detailing primary interview protocols, respondent sampling across clinical and commercial stakeholders, secondary literature synthesis, supply chain mapping, data triangulation, and validation by clinical and industry experts

The research underpinning these insights combines structured primary engagement with clinical and commercial stakeholders and rigorous secondary synthesis of peer-reviewed literature, regulatory documentation, and public policy statements. Primary research involved interviews with respiratory physicians, clinical procurement leads, device engineers, and distribution partners to capture first-hand perspectives on device usability, service expectations, and procurement criteria. These qualitative inputs were complemented by examination of regulatory guidance, published clinical performance studies, and product technical specifications to ensure alignment between stakeholder needs and device capabilities.

Data were triangulated through cross-validation among independent sources, and expert panels comprising clinicians, biomedical engineers, and health system procurement specialists reviewed draft findings to identify material gaps and confirm practical implications. Supply chain mapping exercises traced component origins and manufacturing footprints to evaluate potential exposure to trade policy and logistics risks. Throughout the process, quality assurance protocols were applied to verify citations, confirm factual accuracy, and ensure that conclusions are grounded in verifiable evidence. The methodology prioritizes transparency and reproducibility, enabling stakeholders to understand the basis for conclusions and to commission bespoke analyses that extend the research into specific strategic scenarios.

Concise conclusion summarizing strategic implications for healthcare providers, manufacturers, regulators, and investors with emphasis on clinical performance, interoperability, regulatory alignment, supply resilience, and commercialization priorities

In summary, the spirometer landscape is at an inflection point where clinical expectations, technological innovation, and commercial pressures converge to redefine device utility and deployment. Clinicians expect devices that not only provide accurate physiological measurement but also integrate seamlessly into patient pathways, support remote monitoring, and deliver actionable insights that improve outcomes. Technological advancements across measurement techniques and connectivity are enabling these expectations, while regulatory and procurement considerations shape how solutions move from prototype to clinical use.

For stakeholders, the imperative is clear: prioritize interoperability, ensure rigorous clinical validation across adult and pediatric applications, and build resilient supply chains that can withstand policy and logistical shocks. Commercially, aligning product and service models to the operational realities of ambulatory surgical centers, clinics, hospitals, homecare programs, and research laboratories will determine the pace and breadth of adoption. Ultimately, coordinated efforts across manufacturers, clinicians, payers, and regulators can maximize the clinical and economic value of spirometry, improving patient management and supporting more efficient respiratory care pathways.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Spirometer Market, by Product Type

  • 8.1. Desktop
  • 8.2. Portable
  • 8.3. Stationary

9. Spirometer Market, by Technique

  • 9.1. Fleisch
  • 9.2. Turbine
  • 9.3. Ultrasonic

10. Spirometer Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Clinics
  • 10.3. Homecare Centers
  • 10.4. Hospitals
  • 10.5. Research Laboratories

11. Spirometer Market, by Application

  • 11.1. Adult
  • 11.2. Pediatric

12. Spirometer Market, by Sales Channel

  • 12.1. Offline Sales
  • 12.2. Online Sales

13. Spirometer Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Spirometer Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Spirometer Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Spirometer Market

17. China Spirometer Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Baxter International Inc.
  • 18.6. COSMED S.r.l.
  • 18.7. Fukuda Sangyo Co., Ltd.
  • 18.8. Geratherm Respiratory GmbH
  • 18.9. ICU Medical, Inc.
  • 18.10. Jones Medical Instrument Company
  • 18.11. Koninklijke Philips N.V.
  • 18.12. Medical International Research S.p.A.
  • 18.13. MGC Diagnostics Corporation
  • 18.14. Midmark Corporation
  • 18.15. NDD Medical Technologies AG
  • 18.16. NuvoAir AB
  • 18.17. Schiller AG
  • 18.18. Vitalograph Ltd.
  • 18.19. Vyaire Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPIROMETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPIROMETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPIROMETER MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPIROMETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPIROMETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPIROMETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPIROMETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SPIROMETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPIROMETER MARKET SIZE, BY DESKTOP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPIROMETER MARKET SIZE, BY DESKTOP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPIROMETER MARKET SIZE, BY DESKTOP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPIROMETER MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPIROMETER MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPIROMETER MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPIROMETER MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPIROMETER MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPIROMETER MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPIROMETER MARKET SIZE, BY FLEISCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPIROMETER MARKET SIZE, BY FLEISCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPIROMETER MARKET SIZE, BY FLEISCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPIROMETER MARKET SIZE, BY TURBINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPIROMETER MARKET SIZE, BY TURBINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPIROMETER MARKET SIZE, BY TURBINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPIROMETER MARKET SIZE, BY ULTRASONIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPIROMETER MARKET SIZE, BY ULTRASONIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPIROMETER MARKET SIZE, BY ULTRASONIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPIROMETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPIROMETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPIROMETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPIROMETER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPIROMETER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPIROMETER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPIROMETER MARKET SIZE, BY HOMECARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPIROMETER MARKET SIZE, BY HOMECARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPIROMETER MARKET SIZE, BY HOMECARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPIROMETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPIROMETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPIROMETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPIROMETER MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPIROMETER MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPIROMETER MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPIROMETER MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPIROMETER MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPIROMETER MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPIROMETER MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPIROMETER MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPIROMETER MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPIROMETER MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPIROMETER MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPIROMETER MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPIROMETER MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPIROMETER MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPIROMETER MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPIROMETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS SPIROMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SPIROMETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. GCC SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 111. GCC SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. GCC SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. G7 SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 132. NATO SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. NATO SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL SPIROMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA SPIROMETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA SPIROMETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA SPIROMETER MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA SPIROMETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA SPIROMETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA SPIROMETER MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)